Federated Hermes’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.53M | Buy |
624,303
+209,806
| +51% | +$514K | ﹤0.01% | 1002 |
|
2025
Q1 | $2.76M | Buy |
+414,497
| New | +$2.76M | 0.01% | 861 |
|
2023
Q4 | – | Sell |
-5,197
| Closed | -$106K | – | 2178 |
|
2023
Q3 | $106K | Sell |
5,197
-4,284
| -45% | -$87.8K | ﹤0.01% | 1600 |
|
2023
Q2 | $188K | Sell |
9,481
-1,701
| -15% | -$33.8K | ﹤0.01% | 1559 |
|
2023
Q1 | $192K | Buy |
11,182
+2,028
| +22% | +$34.7K | ﹤0.01% | 1591 |
|
2022
Q4 | $179K | Buy |
9,154
+2,333
| +34% | +$45.7K | ﹤0.01% | 1573 |
|
2022
Q3 | $109K | Sell |
6,821
-276,303
| -98% | -$4.42M | ﹤0.01% | 1605 |
|
2022
Q2 | $3.9M | Sell |
283,124
-144,727
| -34% | -$1.99M | 0.01% | 748 |
|
2022
Q1 | $6.79M | Buy |
+427,851
| New | +$6.79M | 0.02% | 708 |
|
2021
Q2 | – | Sell |
-9,338
| Closed | -$414K | – | 2309 |
|
2021
Q1 | $414K | Sell |
9,338
-6,791
| -42% | -$301K | ﹤0.01% | 1599 |
|
2020
Q4 | $885K | Sell |
16,129
-177,497
| -92% | -$9.74M | ﹤0.01% | 1365 |
|
2020
Q3 | $4.43M | Buy |
+193,626
| New | +$4.43M | 0.01% | 760 |
|
2020
Q2 | – | Sell |
-170,545
| Closed | -$2.38M | – | 2349 |
|
2020
Q1 | $2.38M | Buy |
170,545
+128,734
| +308% | +$1.8M | 0.01% | 836 |
|
2019
Q4 | $952K | Buy |
+41,811
| New | +$952K | ﹤0.01% | 1281 |
|
2019
Q1 | – | Sell |
-403,452
| Closed | -$5.98M | – | 2219 |
|
2018
Q4 | $5.98M | Sell |
403,452
-160,022
| -28% | -$2.37M | 0.02% | 686 |
|
2018
Q3 | $13.9M | Buy |
+563,474
| New | +$13.9M | 0.03% | 459 |
|
2016
Q1 | – | Sell |
-7,500
| Closed | -$340K | – | 2160 |
|
2015
Q4 | $340K | Hold |
7,500
| – | – | ﹤0.01% | 1382 |
|
2015
Q3 | $282K | Buy |
+7,500
| New | +$282K | ﹤0.01% | 1431 |
|